It is widely agreed that the NSE level is a reliable indicator for the differential diagnosis of small cell lung cancer and a useful measure for the monitoring of the therapeutic efficacy of radiotherapy and chemotherapy [12]–[15]. The gene discussed is ENO2; the disease is small cell lung carcinoma.